| |
 |
|
Class Information
Number: 514/381
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > Tetrazoles (including hydrogenated)
Description: Subject matter wherein the five-membered hetero ring consists of four ring nitrogens and one ring carbon and may have double bond between ring members.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7250433 |
Tetrazole and oxadiazolone substituted .beta.-amino acid derivatives |
Jul. 31, 2007 |
| 7230022 |
Substituted fused bicyclic amines as modulators of chemokine receptor activity |
Jun. 12, 2007 |
| 7223780 |
Triazole-derivatives as blood clotting enzyme factor Xa inhibitors |
May. 29, 2007 |
| 7223746 |
Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
May. 29, 2007 |
| 7220734 |
1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists |
May. 22, 2007 |
| 7220771 |
Methods of using indazole derivatives as JNK inhibitors |
May. 22, 2007 |
| 7214701 |
Active substance combinations having insecticidal and acaricdal properties |
May. 8, 2007 |
| 7211594 |
Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
May. 1, 2007 |
| 7208505 |
.beta.3 adrenergic agonists |
Apr. 24, 2007 |
| 7205323 |
Dipeptidyl peptidase IV inhibitors pharmaceutical compositions containing them, and process for their preparation |
Apr. 17, 2007 |
| 7199144 |
Process for the preparation of valsartan and intermediates thereof |
Apr. 3, 2007 |
| 7186749 |
Pyrrolo-naphthyl acids and methods for using them |
Mar. 6, 2007 |
| 7179825 |
Retinoic acid mimetic anilides |
Feb. 20, 2007 |
| 7169797 |
Protein-tyrosine phosphatase inhibitors and uses thereof |
Jan. 30, 2007 |
| 7163942 |
Sulfonamide compounds for the treatment of neurodegenerative disorders |
Jan. 16, 2007 |
| 7157078 |
Devices and methods for eliminating termite colonies |
Jan. 2, 2007 |
| 7138414 |
Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals |
Nov. 21, 2006 |
| 7138415 |
Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
Nov. 21, 2006 |
| 7135490 |
Method for the treatment of glomerulonephritis |
Nov. 14, 2006 |
| 7135491 |
5-Aryltetrazole compounds and uses thereof |
Nov. 14, 2006 |
| 7132437 |
Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension |
Nov. 7, 2006 |
| 7132409 |
Adenosine derivatives and use thereof |
Nov. 7, 2006 |
| 7125869 |
Polycyclic compounds which modulate PPAR.gamma. type receptors and cosmetic/pharmaceutical compositions comprised thereof |
Oct. 24, 2006 |
| 7119090 |
Pyrrole substituted 2-indolinone protein kinase inhibitors |
Oct. 10, 2006 |
| 7115624 |
Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48 |
Oct. 3, 2006 |
| 7112600 |
Fused-ring compounds and use thereof as drugs |
Sep. 26, 2006 |
| 7109203 |
Sulfonamide derivatives |
Sep. 19, 2006 |
| 7105557 |
Polymorphs of valsartan |
Sep. 12, 2006 |
| 7105172 |
Treatment of rosacea |
Sep. 12, 2006 |
| 7105556 |
Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
Sep. 12, 2006 |
| 7101875 |
Methods for treating arthritic disorders |
Sep. 5, 2006 |
| 7091231 |
12-Aryl prostaglandin analogs |
Aug. 15, 2006 |
| 7087631 |
Aryltetrazole compounds, and compositions thereof |
Aug. 8, 2006 |
| 7081467 |
C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals |
Jul. 25, 2006 |
| 7078424 |
N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
Jul. 18, 2006 |
| 7078423 |
5-Aryltetrazole compounds, compositions thereof, and uses therefor |
Jul. 18, 2006 |
| 7074814 |
3-substituted indoles and derivatives thereof as therapeutic agents |
Jul. 11, 2006 |
| 7067546 |
Crystal and process for producing the same |
Jun. 27, 2006 |
| 7064141 |
Method for preventing, treating or inhibiting development of simple retinopathy and preproliferative retinopathy |
Jun. 20, 2006 |
| 7060718 |
Arylsulfonanilide ureas |
Jun. 13, 2006 |
| 7053071 |
Induction of apoptosis in cancer cells |
May. 30, 2006 |
| 7045540 |
Selective estrogen receptor modulators |
May. 16, 2006 |
| 7041659 |
Compounds for the treatment of metabolic disorders |
May. 9, 2006 |
| 7034034 |
Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives |
Apr. 25, 2006 |
| 7026344 |
Treating sickle cell disease |
Apr. 11, 2006 |
| 7022727 |
Crystalline drug form |
Apr. 4, 2006 |
| 7022726 |
.omega.-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
Apr. 4, 2006 |
| 7018986 |
Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption |
Mar. 28, 2006 |
| 7019033 |
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives |
Mar. 28, 2006 |
| 7008959 |
Form of irbesartan, processes for obtaining the said and pharmaceutical compositions containing it |
Mar. 7, 2006 |
|
|
|
